Alaunos Therapeutics (TCRT) Other Non-Current Assets (2009 - 2026)
Alaunos Therapeutics (TCRT) reported Other Non-Current Assets of $831000.0 for Q1 2026, down 21.08% on a YoY basis from $1.1 million in Q1 2025, and down 6.31% quarter-over-quarter from $887000.0 in Q4 2025.
Alaunos Therapeutics (TCRT) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Alaunos Therapeutics has reported Other Non-Current Assets for 17 years, with the latest figure at $831000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets fell 21.08% year-over-year to $831000.0; the trailing twelve-month figure through Mar 2026 stood at $831000.0 (down 21.08% YoY), and the FY2025 full-year result was $887000.0, changed N/A from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $831000.0, down from $887000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $1.1 million in Q1 2025, with the low at $1000.0 in Q2 2023.
- Historically, Other Non-Current Assets has averaged $613909.1 across 4 years, with a median of $500000.0 in 2022.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 24900.0% — and 2023, when it slumped 99.8%.
- Alaunos Therapeutics' Other Non-Current Assets stood at $500000.0 in 2022, then tumbled by 99.8% to $1000.0 in 2023, then soared by 88600.0% to $887000.0 in 2025, then retreated by 6.31% to $831000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $831000.0 (Q1 2026), $887000.0 (Q4 2025), and $942000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - | 831,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 831,000.00 |
| Dec 31, 2025 | 887,000.00 |
| Sep 30, 2025 | 942,000.00 |
| Jun 30, 2025 | 997,000.00 |
| Mar 31, 2025 | 1.05 Mn |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 500,000.00 |
| Dec 31, 2022 | 500,000.00 |
| Sep 30, 2022 | 500,000.00 |
| Jun 30, 2022 | 500,000.00 |
| Mar 31, 2022 | 42,000.00 |
| Dec 31, 2021 | 42,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Jun 30, 2021 | 365,000.00 |
| Mar 31, 2021 | 130,000.00 |
| Dec 31, 2020 | 130,000.00 |
| Sep 30, 2020 | 746,000.00 |
| Jun 30, 2020 | 744,000.00 |
| Mar 31, 2020 | 130,000.00 |
| Dec 31, 2019 | 110,000.00 |